R

Read Gene SA
WSE:RDG

Watchlist Manager
Read Gene SA
WSE:RDG
Watchlist
Price: 4.96 PLN -0.8% Market Closed
Market Cap: 58.5m PLN
Have any thoughts about
Read Gene SA?
Write Note

P/OCF
Price to OCF

-81.7
Current
29
Median
21.9
Industry
Lower than median
Lower than industry value

Price to Operating Cash Flow (P/OCF) ratio is a valuation multiple that measures the value of a company’s market capitalization relative to the operating cash flow it generates. Some analysts prefer P/OCF over P/E since earnings can be more easily manipulated than cash flows.

P/OCF
-81.7
=
Market Cap
58.5m PLN
/
Operating Cash Flow
-716.1k PLN
All Countries
Close
Market Cap P/OCF
PL
Read Gene SA
WSE:RDG
58.5m PLN -81.7
FR
Pharnext SCA
OTC:PNEXF
6T USD -239 690.7
US
Abbvie Inc
NYSE:ABBV
317.9B USD 19.2
US
Amgen Inc
NASDAQ:AMGN
141.7B USD 19.5
US
Gilead Sciences Inc
NASDAQ:GILD
117.1B USD 11.7
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
104.9B USD -124.9
US
Epizyme Inc
F:EPE
94.1B EUR -469.3
AU
CSL Ltd
ASX:CSL
135.7B AUD 30.7
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
78.4B USD 18.4
US
Seagen Inc
F:SGT
39.3B EUR -75.8
NL
argenx SE
XBRU:ARGX
36B EUR -144.4
 
PL
R
Read Gene SA
WSE:RDG
Average P/OCF: 19.9
Negative Multiple: -81.7
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -239 690.7
US
Abbvie Inc
NYSE:ABBV
19.2
US
Amgen Inc
NASDAQ:AMGN
19.5
US
Gilead Sciences Inc
NASDAQ:GILD
11.7
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -124.9
US
E
Epizyme Inc
F:EPE
Negative Multiple: -469.3
AU
CSL Ltd
ASX:CSL
30.7
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
18.4
US
S
Seagen Inc
F:SGT
Negative Multiple: -75.8
NL
argenx SE
XBRU:ARGX
Negative Multiple: -144.4

P/OCF Forward Multiples

Forward P/OCF multiple is a version of the P/OCF ratio that uses forecasted operating cash flow for the P/OCF calculation. 1-Year, 2-Years, and 3-Years forwards use operating cash flow forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
P/OCF
N/A
2-Years Forward
P/OCF
N/A
3-Years Forward
P/OCF
N/A

See Also

Discover More